Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial

CAH Klazen, PNM Lohle, J De Vries, FH Jansen… - The Lancet, 2010 - thelancet.com
Background Percutaneous vertebroplasty is increasingly used for treatment of pain in patients
with osteoporotic vertebral compression fractures, but the efficacy, cost-effectiveness, and …

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection

FH Jansen, RHN van Schaik, J Kurstjens, W Horninger… - European urology, 2010 - Elsevier
Jansen had full access to all the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis. … Drafting of the manuscript: Jansen. …

Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins

FH Jansen, M Roobol, G Jenster, FH Schröder… - European urology, 2009 - Elsevier
Jansen had full access to all the data in the study and takes responsibility for the integrity
of the data and the accuracy of the data analysis. … Drafting of the manuscript: Jansen. …

Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial

…, JR Juttmann, CAH Klazen, OEH Elgersma, FH Jansen… - bmj, 2018 - bmj.com
Objective To assess whether percutaneous vertebroplasty results in more pain relief than a
sham procedure in patients with acute osteoporotic compression fractures of the vertebral …

Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II

…, J De Vries, WJ Van Rooij, FH Jansen… - American Journal …, 2010 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: PV is increasingly used as treatment for osteoporotic
VCFs. However, controversy exists as to whether PV increases the risk for new VCFs during …

First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers

FH Jansen, I Adoubi, KC JC, T De Cnodder… - Anticancer …, 2011 - ar.iiarjournals.org
Background/Aim: Artenimol-R is cytotoxic in transformed cervical cells and safety in humans
is yet to be established. The present study investigates the clinical benefits, safety and the …

[HTML][HTML] Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins

FH Jansen, J Krijgsveld, A van Rijswijk… - Molecular & Cellular …, 2009 - ASBMB
Novel markers for prostate cancer (PCa) are needed because current established markers
such as prostate-specific antigen lack diagnostic specificity and prognostic value. Proteomics …

Bone attenuation on routine chest CT correlates with bone mineral density on DXA in patients with COPD

…, JT Murchison, KF Phang, FH Jansen… - Journal of Bone and …, 2012 - academic.oup.com
Chronic obstructive pulmonary disease (COPD), although primarily a disease of the lungs,
is associated with extrapulmonary effects such as muscle weakness and osteoporosis. …

[HTML][HTML] Progression of osteoporosis in patients with COPD: a 3-year follow up study

…, BEEM van den Borne, MA Spruit, FH Jansen… - Respiratory …, 2012 - Elsevier
Currently, our knowledge on the progression of osteoporosis and its determinants is limited
in patients with chronic obstructive pulmonary disease (COPD). Bone mineral density …

Chemical instability determines the biological action of the artemisinins

FH Jansen, SA Soomro - Current medicinal chemistry, 2007 - ingentaconnect.com
Artemisinin is a sesquiterpene compound of plant origin. It has a low molecular weight, and it
contains five oxygen atoms, two in a lactone function, one is part of a seven membered ring …